From: Viral hemorrhagic fevers: advancing the level of treatment
Virus | Family | Incubation | Virulence | Communicability | Isolation | Treatment option(s) |
---|---|---|---|---|---|---|
Ebola | Filoviridae | 2 to 21 days | High | Yes | Yes | Post-exposure vaccination (rVSV); rNAPc2; siRNA |
Marburg | Filoviridae | 2 to 21 days | High | Yes | Yes | Post-exposure vaccination (rVSV) |
Lassa | Arenaviridae | 6 to 21 days | Moderate | Yes | Yes | Ribavirin |
Lujo | Arenaviridae | 6 to 21 days | High | Yes | Yes | Ribavirin |
Junin | Arenaviridae | 6 to 21 days | Moderate | Yes | Yes | Passive immune therapy |
Machupo | Arenaviridae | 6 to 21 days | Moderate | Yes | Yes | Passive immune therapy |
Sabia | Arenaviridae | 6 to 21 days | Moderate | Unknown | Yes | Â |
Guanarito | Arenaviridae | 6 to 21 days | Moderate | Unknown | Yes | Â |
Chapare | Arenaviridae | 6 to 21 days | Unknown | Unknown | Yes | Â |
Nipah | Paramyxoviridae | 4 to 18 days | High | Potentiala | Yes | Passive immune therapy |
Hendra | Paramyxoviridae | 4 to 18 days | High | Unknown | Yes | Passive immune therapy |
CCHF | Bunyaviridae | 3 to 7 days | Moderate | Yes | Yes | Ribavirin |
Rift Valley fever | Bunyaviridae | 2 to 14 days | Low to moderate | No | No | Ribavirin |
Hantan, Seoul, and so on | Bunyaviridae | Days to months | Low to moderate | No | No | Ribavirinn, hemodialysis |
Sin Nombre, Andes, and so on | Bunyaviridae | Days to months | Moderate | Nob | Nob | ECMO |
Yellow fever | Flaviviridae | 3 to 6 days | Moderate | No | No | Â |
Dengue | Flaviviridae | 3 to 14 days | Low | No | No | Â |
RSSE | Flaviviridae | 7 to 14 days | Moderate | No | No | Â |
Omsk/KFD/AHF | Flaviviridae | 3 to 8 days | Moderate | Unknown | Yes | Â |